Capturing and deciphering the molecular signatures of head and neck cancer

Thomas J. Belbin, Roberto A. Lleras, Richard V. Smith, Nicolas F. Schlecht, Jihyeon Lim, Thomas M. Harris, Geoffrey Childs, Michael B. Prystowsky

Research output: Chapter in Book/Report/Conference proceedingChapter


Head and neck cancer, while relatively uncommon in the United States remains a prevalent condition throughout the world and potentially has substantial quality of life issues for these patients. As a disease classification, head and neck cancer, represents a diverse population of cancers which are linked anatomically, extending from the clavicles to the skull base. There are many histologic types of cancer within this grouping, although the vast majority are squamous cell carcinomas. The most significant disease sites are the oral cavity, oropharynx, larynx and hypopharynx, while other sites, such as the sinuses, are much less common and more heterogeneous. Treatment for head and neck cancer consists of surgery, radiation therapy and chemotherapy, alone or in combination. The decision to use a particular therapeutic regimen has been related to TNM stage, primary site, and comorbidity of the patient. More recently, molecular studies of head and neck cancer, such as global gene expression, methylation status, microRNA and proteomic changes, continue to identify important alterations in the genetic and molecular make-up of these tumors, all of which will be expanded upon in this chapter.

Original languageEnglish (US)
Title of host publicationCancer Genomics
Subtitle of host publicationMolecular Classification, Prognosis and Response Prediction
PublisherSpringer Netherlands
Number of pages34
ISBN (Electronic)9789400758421
ISBN (Print)9400758413, 9789400758414
StatePublished - Sep 1 2013

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Capturing and deciphering the molecular signatures of head and neck cancer'. Together they form a unique fingerprint.

Cite this